#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paraneoplastic neurological syndrome Marginal zone lymphoma recurrent Richter's syndrome Ornithine transcarbamoylase deficiency Idiopathic intracranial hypertension Astrocytoma malignant Aspergillus infection Antiphospholipid antibodies Cardiac arrest Giant cell tumour of tendon sheath Bronchiectasis Neurotrophic keratopathy Neurofibroma Lip and/or oral cavity cancer Glioma More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Basic Information Mantle cell lymphoma – Life with Disease Stevens-Johnson syndrome – Diagnostics Cystic fibrosis – Trials in Disease Combined immunodeficiency – Life with Disease Lymphangioma – Trials in Disease Choroid melanoma – Trials in Disease Sarcoidosis – Trials in Disease Wolfram syndrome – Basic Information Glomerulonephritis membranous – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tucidinostat Anastrozole 7-Ethyl-10-Hydroxycamptothecin Ceftolozane Efanesoctocog Alfa Damoctocog Alfa Pegol Bromocriptine Lenvatinib Poractant Alfa Argipressin Amoxicillin Trihydrate Caspofungin Acetate Dexlansoprazole Labetalol Hydrochloride Cpk850 AMG 732 Mva-209-Fsp-B3 Cefepime Hydrochloride Donepezil Sitravatinib Malate More therapies…

    Learn about Your Condition

    Skin angiosarcoma Medulloblastoma recurrent Amyloidosis Lymphangioma Anaemia Critical illness Malignant fibrous histiocytoma Hot flush Systemic sclerosis pulmonary Pseudomyxoma peritonei Alveolar proteinosis Primary hyperoxaluria Iron overload Osteonecrosis of jaw Lichen sclerosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tinzaparin Sodium
    Portugal Spain

  • Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Ramucirumab
    • Adagrasib
    • Bevacizumab
    Austria Belgium Czechia Denmark Finland France +9

  • Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Relatlimab
    Austria Belgium Czechia France Germany Italy +4

  • Study on the Safety and Effectiveness of Magrolimab with Bevacizumab and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Magrolimab
    • Calcium Levofolinate
    • Bevacizumab
    Belgium France Germany Italy Spain

  • Study of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Sirexatamab
    • Bevacizumab
    • Calcium Folinate
    Germany

  • Study of ZN-c3, Encorafenib, and Cetuximab for Adults with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Azenosertib
    • Encorafenib
    • Cetuximab
    Germany Hungary Italy Poland Spain
Previous Page
1 … 14 15 16 17 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!